Dr. Rafael Riudavets Puig recently completed his PhD in the Mathelier group at NCMM. We caught up with him to learn more about his project and his experience as a PhD student.
Dr Zhuokun Li recently completed her PhD in the Haapeniemi group at NCMM. By screening hundreds of DNA repair protein fusions, Zhuokun’s project aimed to improve the CRISPR-Cas9 gene editing system.
Meet NCMM’s new group leader Biswajyoti Sahu who combines a molecular approach with functional genomics to better understand what happens in disease states such as cancer.
Meet new NCMM Group Leader, Charlotte Boccara, and learn about her plans for interdisciplinary sleep and systems neuroscience research at NCMM, and how she sees her science in the context of society.
Dr Ganna Reint recently completed her PhD in the Haapeniemi group at NCMM. The main goal of Ganna’s PhD project was to further develop the CRISPR Cas9 gene editing method to improve and make it more efficient in achieving precise editing.
Dr. Karolina Spustova recently completed her PhD in the Gözen group at NCMM. Karolina’s project aimed to understand how life evolved on the early Earth from primitive cells to complex systems.
Dr. Nancy Saana Banono completed her PhD in the Esguerra group at NCMM. Nancy’s project examined two different genes and their contributions to the development of neuropsychiatric disorders.
Dr. Marieke Kuijjer, head of the Computational Biology and Systems Medicine Group at NCMM, describes how she collaborates both nationally and internationally, and how it helps to drive her research.
Dr Emma Haapaniemi is head of the Precision Pediatrics and Gene Editing group at NCMM. Here, she describes the impacts and burden that rare immune diseases have on patients and how she is working to help provide them with a cure.
Dr. Johannes Landskron describes how the platform supports researchers with drug discovery and precision medicine projects
The importance of NCMM's group leaders in supporting clinician scientists
Dr. Waszak joined NCMM in March 2020 as head of the Computational Oncology group.
Dr Judith Staerk joined NCMM as a group leader in 2012. Her research focuses on stem cell biology, hematopoietic stem cells and myelodysplastic and myeloproliferative syndromes.
Dr Nikolina Sekulic joined NCMM in 2016. Her main research aim is to better understand the molecular mechanisms that assure genomic stability during cell division. In this profile article, Dr Sekulic discusses her group's current research strategies, her career background, and the day-to-day motivations driving her to make new discoveries.
Dr Sandra Lopez-Aviles joined NCMM in 2011. Her research focusses on understanding the mechanisms controlling cell cycle progression. In this profile article, Dr Lopez-Aviles discusses her group's current focus on the role of protein phosphatases in cell cycle regulation, as well as the potential translational impact of this work.
Dr Camila Esguerra joined NCMM in 2014. Her research involves using zebrafish as a model to study brain function in health and disease. In this profile article, Camila discusses her research career so far, the benefits of using zebrafish in translational research, and her visions and plans for the future.
Dr Emma Haapaniemi joined NCMM as a group leader in January 2019. Her research programme at NCMM will focus on rare immune diseases caused by genetics and rare acquired autoimmune diseases.
Professor Janna Saarela joined NCMM as Director in January 2019. She was previously head of the Technology Centre and Deputy Director of the Institute for Molecular Medicine Finland (FIMM), which is also part of the Nordic EMBL Partnership. Here she shares some insight into her research, and what she hopes the future holds for NCMM.
Marieke Kuijjer started at NCMM as Group Leader for Computational Biology and Systems Medicine in October 2018.
Johannes Landskron, Head of the Chemical Biology Platform at NCMM, shares some insight into how the platform works, and why it is so important for researchers.
Professor Kjetil Taskén is head of the Signalling Networks in Health and Disease Group at NCMM. Here he shares some insight into his group's work with Precision Medicine and Cancer Drug Sensitivity Screening.
The Autophagy Team at NCMM studies processes that lead to intracellular degradation of cytoplasm, collectively referred to as autophagy, or 'self eating'. The team is particularly interested in the role of autophagy in aspects relating to cancer.
Anthony Mathelier's group aims to develop novel bioinformatics tools to aid patient care - We want to create the next generation of cutting-edge algorithms and open computational biology software which have immediate application to real-life biological problems, Mathelier says.
The new group leader at NCMM is one of the few in the world within the research theme of surface-adhered artificial cells. - I am trying to understand what is not driven by its genetic machinery but mostly by the materials properties, Gözen says.
.png?alt=listing)
